Acoziborole
Sponsors
Drugs for Neglected Diseases, Institute of Tropical Medicine, Belgium
Conditions
Gambiense TrypanosomiasisSleeping SicknessTrypanosoma Brucei Gambiense; InfectionTrypanosomiasis, AfricanTrypanosomiasis; African, Due to Trypanosoma Brucei Gambiense, Gambiense
Phase 1
Phase 2
Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense
CompletedNCT03087955
Start: 2016-10-11End: 2020-09-08Updated: 2025-09-17
Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects
CompletedNCT05256017
Start: 2021-12-30End: 2023-08-03Updated: 2025-03-20
Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients
CompletedNCT05433350
Start: 2022-07-09End: 2026-03-31Updated: 2026-04-06